过去一年中添加的文章,按日期排序

Correspondence: Triple Negative Breast Cancer-A Brief Insight Into Pathophysiology

M Agrawal, AK Chowhan - Cancer Control, 2024 - journals.sagepub.com
5 天前 - … the tumor microenvironment can reveal new therapeutic targets such as immunotherapy
and targeted cell therapy… and resistance to therapy. Studies say, detection of circulating …

Turning Waste into Wealth: A Potent Sono-Immune Strategy Based on Microcystis

Y Yang, J Ge, X Zhong, L Liu, L Chen… - … (Deerfield Beach, Fla … - pubmed.ncbi.nlm.nih.gov
5 天前 - … proven in the "cold" 4T1 triple-negative breast tumor. In addition, Me exhibit good …
immunotherapy based on Microcystis that achieved encouraging therapeutic effects on cancer

[HTML][HTML] Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study

C Wang, L Yuan, X Wu, Y Wang, H Tian, G Zhang… - … medicine, 2024 - ncbi.nlm.nih.gov
5 天前 - breast cancer are considered triple-negative breast cancer (TNBC), a subtype of
breast cancer … the KEYNOTE-522 study, immunotherapy was not included in this trial, although …

Ferroptosis as a promising targeted therapy for triple negative breast cancer

K Mokhtarpour, S Razi, N Rezaei - … Cancer Research and Treatment, 2024 - Springer
8 天前 - Triple negative breast cancer (TNBC) is a challenging subtype characterized … -cancer
therapies, including radiotherapy, immunotherapy, chemotherapy, and targeted therapy [3]…

PlexinB1 inactivation reprograms immune cells in the tumor microenvironment, inhibiting breast cancer growth and metastatic dissemination

G Franzolin, S Brundu, CF Cojocaru, A Curatolo… - Cancer Immunology …, 2024 - AACR
8 天前 - … cells in breast cancer Keywords: Plexins, immune cells, immunotherapy, breast
cancer, … (CAIX) protein is an independent prognostic indicator in triple negative breast cancer. …

Identification of disulfidptosis-related clusters and construction of a disulfidptosis-related gene prognostic signature in triple-negative breast cancer

J Wu, Y Cai, G Zhao - Heliyon, 2024 - cell.com
9 天前 - … This study aimed to explore disulfidptosis-related clusters of triple-negative breast
cancer (… to chemotherapy drugs such as lapatinib and had a lower immunotherapy response. …

The expression patterns of different cell types and their interactions in the tumor microenvironment are predictive of breast cancer patient response to neoadjuvant …

SR Dhruba, S Sahni, B Wang, D Wu, PS Rajagopal… - bioRxiv, 2024 - biorxiv.org
9 天前 - … While the TME’s impact on 27 immunotherapy has been extensively studied, its
role in … -associated plasma cells predict improved prognosis in triple negative breast cancer. …

Understanding tissue-resident macrophages unlocks the potential for novel combinatorial strategies in breast cancer

M BISWAS - Frontiers in Immunology - frontiersin.org
9 天前 - … In breast cancer, reprogrammed TRMs may promote disease … cancer cells, deciding
further immunosuppressive or cytotoxic pathways. Moreover, triple-negative breast cancer (…

[PDF][PDF] Pathologic Complete Response to Neoadjuvant Chemotherapy and Pembrolizumab in Postpartum High-Risk Basal-Type Breast Cancer

H Jiang, S Cartwright, DG Wagner, J Krishnamurthy… - Cureus, 2024 - cureus.com
9 天前 - … standard adjuvant endocrine therapy in high-grade ER+ErbB2- breast cancer, but
no … of pCR to pembrolizumab and NAT in a postpartum ER+ErbB2- breast cancer patient with …

[HTML][HTML] Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies

N Xiong, H Wu, Z Yu - Frontiers in Oncology, 2024 - ncbi.nlm.nih.gov
10 天前 - Immunotherapy represents a transformative approach … management of triple-negative
breast cancer (TNBC), a subtype known for its aggressive behavior and limited treatment